After showing significant benefits in delayed disease progression in patients with secondary progressive MS, new data suggests siponimod can delay the time to wheelchair dependence by 4 years.
from Front page feed https://ift.tt/2otjRO2
from Front page feed https://ift.tt/2otjRO2
Comments
Post a Comment